Immunological traits have the potential to improve selection of pigs for resistance to clinical and subclinical disease

2006 ◽  
Vol 82 (5) ◽  
pp. 597-606 ◽  
Author(s):  
M. Henryon ◽  
P. M. H. Heegaard ◽  
J. Nielsen ◽  
P. Berg ◽  
H. R. Juul-Madsen

AbstractIt was reasoned that, if we used a large sample of pigs, we could demonstrate that total and differential numbers of leukocytes, expression levels of swine leukocyte antigens (SLA) I and II, and serum concentrations of IgG and haptoglobin show additive genetic variation and are, therefore, potentially useful as criteria to improve selection of pigs for resistance to clinical and subclinical disease. We tested this premise by assessing 4204 male pigs from the Duroc, Landrace, and Yorkshire breeds for total and differential numbers of leukocytes and serum concentrations of IgG and haptoglobin; 1217 of the Duroc and Landrace pigs were also assessed for expression levels of SLA I and II. We estimated the amount of additive genetic variation by fitting linear animal models to the total and differential numbers of leukocytes and serum concentrations of IgG and haptoglobin. We fitted linear sire models to the expression levels of SLA I and II. We detected additive genetic variation for each group of traits. Total and differential numbers of leukocytes were moderately heritable (h2=0·22 to 0·30), expression levels of SLA I and II were moderate-to-highly heritable (h2=0·46 to 1·23), while serum concentrations of IgG and haptoglobin were lowly heritable (h2=0·14 to 0·16). The additive genetic variation shown for the immunological traits is encouraging for pig breeders. It indicates that these traits are potentially useful as criteria to improve selection of pigs for resistance to clinical and subclinical disease.

2001 ◽  
Vol 73 (3) ◽  
pp. 375-387 ◽  
Author(s):  
M. Henryon ◽  
P. Berg ◽  
J. Jensen ◽  
S. Andersen

AbstractThe objective of this study was to test that genetic variation for resistance to clinical and subclinical diseases exists in growing pigs. A total of 13 551 male growing pigs were assessed for resistance to five categories of clinical and subclinical disease: (i) any clinical or subclinical disease, (ii) lameness, (iii) respiratory diseases, (iv) diarrhoea, and (v) other diseases (i.e. any clinical or subclinical disease with the exception of (ii), (iii), and (iv)). Additive genetic variation for resistance to each disease category was estimated by fitting a Weibull, sire-dam frailty model to time until the pigs were first diagnosed with a disease from that category. Genetic correlations among the resistances to each disease category were approximated as product-moment correlations among predicted breeding values of the sires. Additive genetic variation was detected for resistance to (i) any clinical or subclinical disease (additive genetic variance for log-frailty (± s.e.) = 0·18 ± 0·05, heritability on the logarithmic-time scale = 0·10), (ii) lameness (0·29 ± 0·11, 0·16), (iii) respiratory diseases (0·24 ± 0·16, 0·12), (iv) diarrhoea (0·30 ± 0·27, 0·16), and (v) the other diseases (0·34 ± 0·15, 0·19) and there were generally positive and low-to-moderate correlations among the predicted breeding values (-0·03 to + 0·65). These results demonstrate that additive genetic variation for resistance to clinical and subclinical diseases does exist in growing pigs, and suggests that selective breeding for resistance could be successful.


Molecules ◽  
2021 ◽  
Vol 26 (14) ◽  
pp. 4221
Author(s):  
Aage Kristian Olsen Alstrup ◽  
Svend Borup Jensen ◽  
Ole Lerberg Nielsen ◽  
Lars Jødal ◽  
Pia Afzelius

The development of new and better radioactive tracers capable of detecting and characterizing osteomyelitis is an ongoing process, mainly because available tracers lack selectivity towards osteomyelitis. An integrated part of developing new tracers is the performance of in vivo tests using appropriate animal models. The available animal models for osteomyelitis are also far from ideal. Therefore, developing improved animal osteomyelitis models is as important as developing new radioactive tracers. We recently published a review on radioactive tracers. In this review, we only present and discuss osteomyelitis models. Three ethical aspects (3R) are essential when exposing experimental animals to infections. Thus, we should perform experiments in vitro rather than in vivo (Replacement), use as few animals as possible (Reduction), and impose as little pain on the animal as possible (Refinement). The gain for humans should by far exceed the disadvantages for the individual experimental animal. To this end, the translational value of animal experiments is crucial. We therefore need a robust and well-characterized animal model to evaluate new osteomyelitis tracers to be sure that unpredicted variation in the animal model does not lead to a misinterpretation of the tracer behavior. In this review, we focus on how the development of radioactive tracers relies heavily on the selection of a reliable animal model, and we base the discussions on our own experience with a porcine model.


2021 ◽  
Vol 15 (1) ◽  
Author(s):  
Weitong Cui ◽  
Huaru Xue ◽  
Lei Wei ◽  
Jinghua Jin ◽  
Xuewen Tian ◽  
...  

Abstract Background RNA sequencing (RNA-Seq) has been widely applied in oncology for monitoring transcriptome changes. However, the emerging problem that high variation of gene expression levels caused by tumor heterogeneity may affect the reproducibility of differential expression (DE) results has rarely been studied. Here, we investigated the reproducibility of DE results for any given number of biological replicates between 3 and 24 and explored why a great many differentially expressed genes (DEGs) were not reproducible. Results Our findings demonstrate that poor reproducibility of DE results exists not only for small sample sizes, but also for relatively large sample sizes. Quite a few of the DEGs detected are specific to the samples in use, rather than genuinely differentially expressed under different conditions. Poor reproducibility of DE results is mainly caused by high variation of gene expression levels for the same gene in different samples. Even though biological variation may account for much of the high variation of gene expression levels, the effect of outlier count data also needs to be treated seriously, as outlier data severely interfere with DE analysis. Conclusions High heterogeneity exists not only in tumor tissue samples of each cancer type studied, but also in normal samples. High heterogeneity leads to poor reproducibility of DEGs, undermining generalization of differential expression results. Therefore, it is necessary to use large sample sizes (at least 10 if possible) in RNA-Seq experimental designs to reduce the impact of biological variability and DE results should be interpreted cautiously unless soundly validated.


Genetics ◽  
1992 ◽  
Vol 130 (1) ◽  
pp. 223-227
Author(s):  
A Gimelfarb

Abstract It is demonstrated that systems of two pleiotropically related characters controlled by additive diallelic loci can maintain under Gaussian stabilizing selection a stable polymorphism in more than two loci. It is also shown that such systems may have multiple stable polymorphic equilibria. Stabilizing selection generates negative linkage disequilibrium, as a result of which the equilibrium phenotypic variances are quite low, even though the level of allelic polymorphisms can be very high. Consequently, large amounts of additive genetic variation can be hidden in populations at equilibrium under stabilizing selection on pleiotropically related characters.


1984 ◽  
Vol 43 (3) ◽  
pp. 307-321 ◽  
Author(s):  
Billy W. Geer ◽  
Cathy C. Laurie-Ahlberg

SUMMARYGenetic variation in the modulating effect of dietary sucrose was assessed in Drosophila melanogaster by examining 27 chromosome substitution lines coisogenic for the X and second chromosomes and possessing different third isogenic chromosomes derived from natural populations. An increase in the concentration of sucrose from 0·1% to 5% in modified Sang's medium C significantly altered the activities of 11 of 15 enzyme activities in third instar larvae, indicating that dietary sucrose modulates many, but not all, of the enzymes of D. melanogaster. A high sucrose diet promoted high activities of enzymes associated with lipid and glycogen synthesis and low activities of enzymes of the glycolytic and Krebs cycle pathways, reflecting the physiological requirements of the animal. Analyses of variance revealed significant genetic variation in the degrees to which sucrose modulated several enzyme activities. Analysis of correlations revealed some relationships between enzymes in the genetic effects on the modulation process. These observations suggest that adaptive evolutionary change may depend in part on the selection of enzyme activity modifiers that are distributed throughout the genome.


2016 ◽  
Vol 82 (8) ◽  
pp. 2240-2246 ◽  
Author(s):  
Alex I. Kanno ◽  
Cibelly Goulart ◽  
Henrique K. Rofatto ◽  
Sergio C. Oliveira ◽  
Luciana C. C. Leite ◽  
...  

ABSTRACTThe expression of many antigens, stimulatory molecules, or even metabolic pathways in mycobacteria such asMycobacterium bovisBCG orM. smegmatiswas made possible through the development of shuttle vectors, and several recombinant vaccines have been constructed. However, gene expression in any of these systems relied mostly on the selection of natural promoters expected to provide the required level of expression by trial and error. To establish a systematic selection of promoters with a range of strengths, we generated a library of mutagenized promoters through error-prone PCR of the strong PL5promoter, originally from mycobacteriophage L5. These promoters were cloned upstream of the enhanced green fluorescent protein reporter gene, and recombinantM. smegmatisbacteria exhibiting a wide range of fluorescence levels were identified. A set of promoters was selected and identified as having high (pJK-F8), intermediate (pJK-B7, pJK-E6, pJK-D6), or low (pJK-C1) promoter strengths in bothM. smegmatisandM. bovisBCG. The sequencing of the promoter region demonstrated that it was extensively modified (6 to 11%) in all of the plasmids selected. To test the functionality of the system, two different expression vectors were demonstrated to allow corresponding expression levels of theSchistosoma mansoniantigen Sm29 in BCG. The approach used here can be used to adjust expression levels for synthetic and/or systems biology studies or for vaccine development to maximize the immune response.


2018 ◽  
Vol 137 (6) ◽  
pp. 928-935 ◽  
Author(s):  
Mozhgan Abtahi ◽  
Mohammad Mahdi Majidi ◽  
Behnam Hoseini ◽  
Aghafakhr Mirlohi ◽  
Bahram Araghi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document